Back to Search
RICHARD WOMER, M.D.
M.D.
Pediatric Hematology & Oncology Physician
NPI: 1306850631Individual
Specialties, Licenses & Credentials
Pediatrics Physician
Pediatrics
Code: 208000000X
MD027226E(PA)
Pediatric Hematology & Oncology PhysicianPrimary
Pediatrics — Pediatric Hematology-Oncology
Code: 2080P0207X
MD027226E(PA)
Research & Publications (20)
Granulocyte colony stimulating factor permits dose intensification by interval compression in the treatment of Ewing's sarcomas and soft tissue sarcomas in children.
PMID 10741300·Eur J Cancer·2000
8-other
Multidisciplinary systems approach to chemotherapy safety: rebuilding processes and holding the gains.
PMID 12488417·J Clin Oncol·2002
8-other
Genitourinary rhabdomyosarcoma: which treatment, how much, and when?
PMID 19640790·J Pediatr Urol·2009
6-review
Addition of muramyl tripeptide to chemotherapy for patients with newly diagnosed metastatic osteosarcoma: a report from the Children's Oncology Group.
PMID 19637348·Cancer·2009
3-trial
Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: a Children's Oncology Group Study.
PMID 19349548·J Clin Oncol·2009
4-observational
Effect of time to resumption of chemotherapy after definitive surgery on prognosis for non-metastatic osteosarcoma.
PMID 19255220·J Bone Joint Surg Am·2009
8-other
Imaging guidelines for children with Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group Bone Tumor Committee.
PMID 18454470·Pediatr Blood Cancer·2008
6-review
Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.
PMID 18235123·J Clin Oncol·2008
4-observational
Molecular diagnosis of ewing family tumors: too many fusions... ?
PMID 17652636·J Mol Diagn·2007
8-other
Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma.
PMID 16782927·J Clin Oncol·2006
2-rct
Prognostic factors in children with extragonadal malignant germ cell tumors: a pediatric intergroup study.
PMID 16735707·J Clin Oncol·2006
8-other
Long-term follow-up and prognosis of orbital apex syndrome resulting from nasopharyngeal rhabdomyosarcoma.
PMID 16023064·Am J Ophthalmol·2005
5-case
Amifostine does not protect against the ototoxicity of high-dose cisplatin combined with etoposide and bleomycin in pediatric germ-cell tumors: a Children's Oncology Group study.
PMID 15999362·Cancer·2005
8-other
Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate.
PMID 15774791·J Clin Oncol·2005
3-trial
Early molecular detection of central nervous system relapse in a child with systemic anaplastic large cell lymphoma: case report and review of the literature.
PMID 15515044·Pediatr Blood Cancer·2005
5-case
Age is a risk factor for chemotherapy-induced hepatopathy with vincristine, dactinomycin, and cyclophosphamide.
PMID 15143082·J Clin Oncol·2004
3-trial
Predicting cisplatin ototoxicity in children: the influence of age and the cumulative dose.
PMID 15519518·Eur J Cancer·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3401 CIVIC CENTER BLVD, CHILDREN'S HOSPITAL OF PHILADELPHIA - HEM/ONC
PHILADELPHIA, PA 19104 - Phone
- (215) 590-3535
Quick Facts
- NPI
- 1306850631
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile